Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disorders

US9085584B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Riccardo Giovannini · Verona, IT
• Barbara Bertani · Castiglione delle Stiviere, IT
• Sara Frattini · Castelleone, IT
• Giustino DI ANTONIO · Sant'Egidio alla Vibrata, IT
• Hans-Joachim Lankau · Weinböhla, DE
• Hans Stange · Riesa, DE
• Christian Grunwald · Dresden, DE
• Norbert Höfgen · Radeberg, DE
• Barbara Langen · Radebeul, DE
• Ute Egerland · Radebeul, DE

Key dates

• Filing date: Jul 26, 2013
• Grant date: Jul 21, 2015
• Expiry date: Jul 26, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The compounds are of the class of pyrido[3,2-e][1,2,4]-tiazolo[4,3-a]pyrazines, useful in the treatment of central nervous system disorders. A species illustrative of members of the class is the following: